NMRA vs TFC · $283.5M cap vs rev $24.54B
Neumora Therapeutics, Inc. (NMRA) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
TFC (TFC) common stock.
NMRA does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
NMRA currently screens at market cap $283.5M. TFC currently screens at market cap $0.
Not investment advice. Open the NMRA and TFC stock pages for the full models.
Not investment advice.